1. Ma Q#, Wang J#, Qi J#, Peng D#, Guan B, Zhang J, Li Z, Zhang H, Li T, Shi Y, Li X*, Zhou L*, Chen K*, Ci W*. Increased chromosomal instability characterizes metastatic renal cell carcinoma. Translational Oncology 14 (2021) 100929.

2. Han Y#, Li X#, Zhang M#, Yang Y#, Ge G, Wang K，Gong Y, Liang Y, Niu H*, Ci W*. Enhanced detection of genitourinary cancers using fragmentation and copy number profiles obtained from urinary cell-free DNA. Clinical Chemistry. 2020.

3. Wu Z#, Shi Y#, Lu M#, Song M, Yu Z, Wang J, Wang S, Ren J, Yang YG, Liu GH*, Zhang W*, Ci W*, Qu J*. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA. Nucleic Acids Research. 2020, doi: 10.1093/nar/gkaa816.

4. Lu H#, Liang Y#, Guan B#, Shi Y, Gong Y, Li J, Kong W, Liu J, Fang D, Liu L, He Q, Shakeel M, Li X*, Zhou L*, Ci W*. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma. Theranostics. 2020,10(10): 4323-4333.

5. Xu Z#, Ge G#, Guan B#, Lei Z#, Hao X, Zhou Y, Shi Y, Lu H, Wang J, Peng D, Wu K, He H, Zhang B, Li X, Zhou L*, Ci W*. Non-invasive detection and localization of genitourinary cancers using urinary sediment DNA methylomes and copy number profiles. European Urology. 2020,77(2):288-290.

6. Ge G#, Peng D#, Guan B#, Zhou Y#, Gong Y#, Shi Y#, Hao X, Xu Z, Qi J, Lu H, Zhang X, Zhan Y, Li Y, Wu Y, Ding G, Shen Q, He Q, Li X*, Zhou L*, Ci W*. Detection of urothelial carcinoma based on copy number profiles of urinary cell-free DNA using shallow whole-genome sequencing. Clinical Chemistry. 2020, 66(1):188–198.

7. Ma Q, Xu Z, Lu H, Xu ZY, Zhou Y, Yuan B, Ci W*. Distal regulatory elements identified by methylation and hydroxymethylation haplotype blocks from mouse brain. Epigenetics Chromatin. 2018,11(1):75.

8. Peng D#, Ge G, Xu Z, Ma Q, Shi Y, Zhou Y, Gong Y, Xiong G, Zhang C, He S, He Z, Li X*, Ci W*, Zhou L*. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation. Epigenomics. 2018,10(9):1189-1199.

9. Peng D#, Ge G, Gong Y, Zhan Y, He S, Guan B, Li Y, Xu Z, Hao H, He Z, Xiong G, Zhang C, Shi Y, Zhou Y, Ci W*, Li X*, Zhou L*. Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer. Clinical Epigenetics. 2018;10(1):94.

10. Ge G#, Peng D#, Xu Z#, G B, Xin Z, He Q, Zhou Y, Li X*, Zhou L*, Ci W*. Restoration of 5-hydroxymethylcytosine by ascorbate blocks kidney tumour growth, EMBO Reports, 2018, 19(8).pii: e45401.

11. Ma Q #, Lu H, Xu Z, Zhou Y, and Ci W*. Mouse Olfactory Bulb Methylome and Hydroxymethylome Maps Reveal Noncanonical Active Turnover of DNA Methylation. Epigenetics, 2017, 25:1-7.

12. Valls, E#, Lobry C#, Geng H, Wang L, Cardenas M, Rivas M, Cerchietti L, Oh P, Yang S, Oswald E, Graham C, Jiang Y, Hatzi K, Agirre X, Perkey E, Li Z, Tam W, Bhatt K, Leonard J, Zweidler-McKa P, Maillard P, Elemento O, Ci W*, Aifantis I*, Melnick A*. BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells, Cancer Discovery, 2017,7(5):506-521.

13. Chen K#, Zhang J#, Guo Z#, Ma Q, Xu Z, Zhou Y, Xu Z, Li Z, Liu Y, Ye X, Li X, Yuan B, Ke Y, He C, Zhou L*, Liu J*, Ci W*. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer, Cell Research, 2016, 26(1):103-118.

14. Ci W# and Liu J*.Programming and Inheritance of Parental DNA Methylomes in Vertebrates, Physiology, 2015, 30(1): 63– 68.

15. Li G#, Ci W#, Karmakar S#, Chen K, Dhar R, Fan Z, Guo Z, Zhang J, Ke Y, Wang L, Zhuang M, Hu S, Li X, Zhou L, Li X, Calabrese MF, Watson ER, Prasad SM, Rinker-Schaeffer C, Eggener SE, Stricker T, Tian Y, Schulman BA, Liu J*, White KP*. SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer, Cancer Cell, 2014, 25(4)：455-468.

16. Jiang L#, Zhang J#, Wang J#, Wang L, Zhang L, Li G, Yang X, Ma X, Sun X, Cai J, Zhang J, Huang X, Yu M, Wang X, Liu F, Wu CI, He C, Zhang B, Ci W*, Liu J*.Sperm, but Not Oocyte, DNA Methylome Is Inherited by Zebrafish Early Embryos, Cell, 2013, 153(4):773-784.

17. Ci W#, Polo JM, Cerchietti L, Shaknovich R, Wang L, Yang SN, Ye K, Farinha P, Horsman DE, Gascoyne RD, Elemento O, Melnick A*.The BCL6 transcriptional program features repression of multiple oncogenes in primary B-cells and is deregulated in DLBCL. Blood, 2009, 113(22):5536-5348.

18. Polo JM#, Ci W#, Licht J, Melnick A*, Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B-cells. Blood, 2008, 112(3):644-651.

19. Ci W#, Polo JM#, Melnick A*. B-cell lymphoma 6 and the molecular pathogenesis of non-Hodgkin’s lymphoma. 2008. Curr Opin Hematol. 15(4):381-390.

专业技术职务：
职　　务：
电子邮件：
学科类别：